Round Type
Venture
MinneapolisManufacturingBiotechnologyHealth CareTherapeuticsInvestors
Description
Bio-Techne Corporation (NASDAQ:TECH) today announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target of $55 million, triggering Bio-Techne's initial investment in the company, which is expected to close at the end of March 2023. Bio-Techne's $257 million investment will give the Company a 20% ownership stake in Wilson Wolf. The agreement includes the right to acquire the remaining ownership in Wilson Wolf for $1 billion upon its achievement of $226 million in trailing 12-month revenue or $136 million in EBITDA. If the remaining milestone is not met by December 31, 2027, Bio-Techne has the right to acquire Wilson Wolf for ~4.4x trailing 12-month revenue.
Quick answer
Wilson Wolf Manufacturing raised an undisclosed amount in a funding round, dated March 1, 2023. Investors: Bio Techne, Techne, Wilson Wolf Manufacturing and Bio Techne Corporation. Wilson Wolf Manufacturing is based in Minneapolis, Minnesota, United States.
- How much did Wilson Wolf Manufacturing raise?
- Wilson Wolf Manufacturing raised an undisclosed amount in a funding round on March 1, 2023.
- Who invested in Wilson Wolf Manufacturing?
- Bio Techne, Techne, Wilson Wolf Manufacturing and Bio Techne Corporation are named as investors in this round.
- What does Wilson Wolf Manufacturing do?
- Wilson Wolf, headquartered in St. Paul, Minnesota, is an innovative leader in the development, and manufacture of cell production technology for use in the groundbreaking healthcare field of Cell and Gene Therapy (CGT).
- Where is Wilson Wolf Manufacturing based and how big is it?
- Wilson Wolf Manufacturing is based in Minneapolis, Minnesota, United States.
- Who are the decision-makers at Wilson Wolf Manufacturing?
- Fundz holds 1 contact at Wilson Wolf Manufacturing, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as Wilson Wolf Manufacturing that raised within 45 days of this round, from Fundz verified event records.
- Virax Biolabs raised $4M on March 10, 2023.
- Lapix Therapeutics raised $5.9M on April 14, 2023.
- TransCode Therapeutics raised an undisclosed amount on April 14, 2023.
- OncoLize raised $1.7M (Seed) on April 13, 2023.
- Persist AI raised $4.9M (Seed) on April 13, 2023.
- Amend Surgical raised an undisclosed amount (Funding Round) on April 11, 2023.
Who to call at Wilson Wolf Manufacturing, and when
A new round usually means Wilson Wolf Manufacturing is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Wilson Wolf Manufacturing raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Wilson Wolf Manufacturing, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Wilson Wolf Manufacturing. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Wilson Wolf Manufacturing raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Wilson Wolf Manufacturing raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.